World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
85
Citations
27950
World Ranking
14550
National Ranking
7363

Mary Lee Vance publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Mary Lee Vance sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 245 publications — 7th percentile

7% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Mary Lee Vance D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Mary Lee Vance sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 85 D-Index — 29th percentile

29% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Mary Lee Vance is affiliated with the University of Virginia in the United States. Their research mainly spans fields of Biochemistry, Genetics and Molecular Biology, and Medicine. Within these, the scientist has contributed notably to Molecular Biology, Neurology, Oncology, Cancer Research, and Endocrinology, Diabetes and Metabolism.

Their work addresses several critical topics, including:

  • Cerebrovascular and genetic disorders
  • Angiogenesis and VEGF in Cancer
  • Cancer, Hypoxia, and Metabolism
  • Melanoma and MAPK Pathways
  • CAR-T cell therapy research
  • Epigenetics and DNA Methylation
  • Fibroblast Growth Factor Research

Key recent papers authored by or involving Mary Lee Vance include:

  • Vascular smooth muscle cell-specific Igf1r deficiency exacerbates the development of hypertension-induced cerebral microhemorrhages and gait defects, 2024, GeroScience
  • IGF1R deficiency in vascular smooth muscle cells impairs myogenic autoregulation and cognition in mice, 2024, Frontiers in Aging Neuroscience
  • Microvascular smooth muscle cells exhibit divergent phenotypic switching responses to platelet-derived growth factor and insulin-like growth factor 1, 2023, Microvascular Research
  • 1108P Real world (RW) sequencing outcomes with immunotherapy and targeted therapy (TT) in BRAF+ metastatic melanoma (The NOBLE study series), 2020, Annals of Oncology
  • 1111P Suboptimal real-world (RW) outcomes for BRAF+ metastatic melanoma (MM) patients in 2L therapy (The NOBLE study series), 2020, Annals of Oncology

The scientist frequently collaborates with colleagues such as Shannon M. Conley, Marisa A. Bickel, Elizabeth C. Bullen, Eric W. Howard, and Lauren R. Miller, with multiple coauthored works reflecting sustained research partnerships.

Mary Lee Vance's publications appear regularly in venues such as Annals of Oncology, GeroScience, Frontiers in Aging Neuroscience, Microvascular Research, and SSRN Electronic Journal, showing a focus on both clinical and molecular aspects of disease processes.

Best Publications

  • Diagnosis and Complications of Cushing’s Syndrome: A Consensus Statement

    G. Arnaldi;A. Angeli;A. B. Atkinson;X. Bertagna

  • The prevalence of pituitary adenomas: a systematic review.

    Shereen Ezzat;Sylvia L. Asa M.D.;William T. Couldwell;M.P.H. Charles E. Barr M.D.

  • Evaluation and Treatment of Adult Growth Hormone Deficiency: An Endocrine Society Clinical Practice Guideline

    Mark E. Molitch;David R. Clemmons;Saul Malozowski;George R. Merriam

  • Treatment of Adrenocorticotropin-Dependent Cushing’s Syndrome: A Consensus Statement

    B.M.K. Biller;Ashley Barry Grossman;P.M. Stewart;Shlomo Melmed

  • Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant.

    Trainer Pj;Drake Wm;Katznelson L;Freda Pu

  • Guidelines for Acromegaly Management: An Update

    S. Melmed;A. Colao;A. Barkan;Mark E Molitch

  • Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist

    Aart Jan van der Lely;R Kent Hutson;Peter J Trainer;G Michael Besser

  • Pituitary incidentaloma: an endocrine society clinical practice guideline.

    Pamela U. Freda;Albert M. Beckers;Laurence Katznelson;Mark E. Molitch

  • CLINICAL PRACTICE GUIDELINE Evaluation and Treatment of Adult Growth Hormone Deficiency: An Endocrine Society Clinical Practice Guideline

    Mark E. Molitch;David R. Clemmons;Saul Malozowski;George R. Merriam

  • Guidelines for Acromegaly Management

    S. Melmed;F. F. Casanueva;F. Cavagnini;P. Chanson

  • Surgical Management of GH-Secreting Pituitary Adenomas: An Outcome Study Using Modern Remission Criteria

    J. Kreutzer;M. L. Vance;M. B. S. Lopes;E. R. Laws

  • Octreotide Treatment of Acromegaly: A Randomized, Multicenter Study

    Shereen Ezzat;Peter J. Snyder;William Francis Young;Louis D. Boyajy

  • Growth Hormone Therapy in Adults and Children

    Mary Lee Vance;Nelly Mauras

  • Endoscopic transsphenoidal surgery for acromegaly: remission using modern criteria, complications, and predictors of outcome.

    John A. Jane;Robert M. Starke;Mohamed A. Elzoghby;Mohamed A. Elzoghby;Davis L. Reames

  • Safety and efficacy of long-term octreotide therapy of acromegaly: Results of a multicenter trial in 103 patients—a clinical research center study

    C B Newman;S Melmed;P J Snyder;W F Young

  • Late recurrences of Cushing's disease after initial successful transsphenoidal surgery.

    Chirag G. Patil;Daniel M. Prevedello;Shivanand P. Lad;Mary Lee Vance

  • Octreotide as primary therapy for acromegaly

    Connie B. Newman;Shlomo Melmed;Ajax George;Drew Torigian

  • Drugs Five Years Later: Bromocriptine

    Mary Lee Vance;William S. Evans;Michael O. Thorner

  • Enhanced basal and disorderly growth hormone secretion distinguish acromegalic from normal pulsatile growth hormone release.

    M L Hartman;S M Pincus;M L Johnson;D H Matthews

  • Consensus statement: medical management of acromegaly

    S Melmed;F Casanueva;F Cavagnini;P Chanson

Frequent Co-Authors

Edward R. Laws
Edward R. Laws Brigham and Women's Hospital
Michael O. Thorner
Michael O. Thorner University of Virginia
Jason P. Sheehan
Jason P. Sheehan University of Virginia
Wylie Vale
Wylie Vale Salk Institute for Biological Studies
Jean Rivier
Jean Rivier Salk Institute for Biological Studies
Alan D. Rogol
Alan D. Rogol University of Virginia
John A. Jane
John A. Jane University of Virginia Health System
Anne Klibanski
Anne Klibanski Harvard University
Shlomo Melmed
Shlomo Melmed Cedars-Sinai Medical Center
Mark E. Molitch
Mark E. Molitch Northwestern University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Aspiring medical professionals have increasingly flexible options through online degree programs. Whether you are starting your journey or looking to advance your career, online education can help you meet your goals while balancing work and personal responsibilities.

If you're considering nursing, a common concern is how much does online nursing school cost. Tuition can vary significantly depending on the institution and program, but researching affordable options can help reduce financial barriers.

For registered nurses looking to enhance their credentials, exploring the cheapest rn to bsn program offerings can be a practical step. Many of these programs are designed for working professionals and can be completed at your own pace.

Those interested in advanced practice roles might consider a phd nursing education online or pursue specialized direct entry options. Additionally, direct entry nurse practitioner programs for non-nurses online create new career avenues for those coming from different backgrounds.

Exploring these online pathways not only opens doors to new professions but also offers greater flexibility and affordability for future medical practitioners.

Best Scientists Citing Mary Lee Vance

Trending Scientists

Recently Published Articles